Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1130
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04108195 | A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma | ||
| NCT01597739 | A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy | ||
| NCT03693391 | A Study to Investigate Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA Gamma 8) Receptor Occupancy of JNJ-64140284 With Newly Developed Transmembrane AMPA Receptor Regulatory Protein (TARP)-Gamma 8 Positron Emission Tomography (PET) [18F]JNJ-64511070 in Healthy Men | ||
| NCT01643889 | A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers | ||
| NCT06750094 | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy | ||
| NCT06649695 | A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis | ||
| NCT05242445 | A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus Infection | ||
| NCT03234972 | A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT03010059 | A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations | ||
| NCT01826786 | The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Volunteers | ||
| NCT01722487 | Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL | ||
| NCT04634552 | A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT04844411 | A Study of JNJ-67835989 in Healthy Participants | ||
| NCT02271438 | A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants | ||
| NCT02841150 | Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules | ||
| NCT04087759 | A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001) in Healthy Adult Participants | ||
| NCT04193046 | A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) | ||
| NCT04836559 | A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy | ||
| NCT03162796 | A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) | ||
| NCT03438461 | A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Different Formulations in Healthy Participants Under Fasted and Semi-fasted Conditions | ||
| NCT03002779 | A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose in Healthy Male Participants | ||
| NCT01679951 | A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate | ||
| NCT04973566 | A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants | ||
| NCT06398457 | Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies | ||
| NCT05784129 | A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection | ||
| NCT03474757 | Treatment Pattern of NOACs (Non-vitamin K Oral Anticoagulants) in Outpatient Users in Colombian Databases | ||
| NCT01077362 | A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents | ||
| NCT01658722 | Retrieval of Patient Information After Discontinuation | ||
| NCT04662580 | ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer | ||
| NCT04552197 | A Study of JNJ-64251330 in Healthy Participants | ||
| NCT05112952 | A Study to Evaluate the Effect of Hepatic Impairment on Lazertinib (JNJ-73841937) | ||
| NCT02234843 | EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis | ||
| NCT03586843 | A Study of JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple Dose | ||
| NCT01081834 | The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial | ||
| NCT03535558 | Fluoroquinolone Associated Disability | ||
| NCT03298906 | A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants | ||
| NCT02851212 | A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants | ||
| NCT06604715 | A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT04671433 | Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene | ||
| NCT05123599 | A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection | ||
| NCT03586830 | A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus | ||
| NCT03473730 | Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer | ||
| NCT07499232 | A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease | ||
| NCT01063881 | The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy | ||
| NCT02889367 | A Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of Odalasvir Administered as a Single Dose Tablet Under Fed Conditions in Healthy Participants | ||
| NCT05841030 | A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) | ||
| NCT04235270 | A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants | ||
| NCT03502694 | Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus | ||
| NCT03795402 | Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling | ||
| NCT01106690 | The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone) |
